107 related articles for article (PubMed ID: 15133197)
1. Synthesis and biological activity of novel retinamide and retinoate derivatives.
Um SJ; Kwon YJ; Han HS; Park SH; Park MS; Rho YS; Sin HS
Chem Pharm Bull (Tokyo); 2004 May; 52(5):501-6. PubMed ID: 15133197
[TBL] [Abstract][Full Text] [Related]
2. Comparison of N-(4-hydroxyphenyl)retinamide and all-trans-retinoic acid in the regulation of retinoid receptor-mediated gene expression in human breast cancer cell lines.
Kazmi SM; Plante RK; Visconti V; Lau CY
Cancer Res; 1996 Mar; 56(5):1056-62. PubMed ID: 8640761
[TBL] [Abstract][Full Text] [Related]
3. Potent cytotoxic effects of novel retinamide derivatives in ovarian cancer cells.
Um SJ; Sin HS; Han HS; Kwon YJ; Kim EJ; Park SH; Kim SY; Bae TS; Park JS; Rho YS
Biol Pharm Bull; 2003 Oct; 26(10):1412-7. PubMed ID: 14519946
[TBL] [Abstract][Full Text] [Related]
4. Potent effect of 5-HPBR, a butanoate derivative of 4-HPR, on cell growth and apoptosis in cancer cells.
Han HS; Kwon YJ; Park SH; Kim EJ; Rho YS; Sin HS; Um SJ
Int J Cancer; 2004 Mar; 109(1):58-64. PubMed ID: 14735468
[TBL] [Abstract][Full Text] [Related]
5. N-(4-hydroxyphenyl)retinamide (4-HPR)-mediated biological actions involve retinoid receptor-independent pathways in human breast carcinoma.
Sheikh MS; Shao ZM; Li XS; Ordonez JV; Conley BA; Wu S; Dawson MI; Han QX; Chao WR; Quick T
Carcinogenesis; 1995 Oct; 16(10):2477-86. PubMed ID: 7586155
[TBL] [Abstract][Full Text] [Related]
6. Antiproliferative mechanism of retinoid derivatives in ovarian cancer cells.
Um SJ; Lee SY; Kim EJ; Han HS; Koh YM; Hong KJ; Sin HS; Park JS
Cancer Lett; 2001 Dec; 174(2):127-34. PubMed ID: 11689287
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effects of fenretinide metabolites N-[4-methoxyphenyl]retinamide (MPR) and 4-oxo-N-(4-hydroxyphenyl)retinamide (3-keto-HPR) on fenretinide molecular targets β-carotene oxygenase 1, stearoyl-CoA desaturase 1 and dihydroceramide Δ4-desaturase 1.
Poliakov E; Samuel W; Duncan T; Gutierrez DB; Mata NL; Redmond TM
PLoS One; 2017; 12(4):e0176487. PubMed ID: 28448568
[TBL] [Abstract][Full Text] [Related]
8. Nuclear retinoid receptors are involved in N-(4-hydroxyphenyl) retinamide (Fenretinide)-induced gene expression and growth inhibition in HL-60 acute myeloid leukemia cells.
Ozpolat B; Tari AM; Mehta K; Lopez-Berestein G
Leuk Lymphoma; 2004 May; 45(5):979-85. PubMed ID: 15291358
[TBL] [Abstract][Full Text] [Related]
9. Retinoid receptor-dependent and independent biological activities of novel fenretinide analogues and metabolites.
Sabichi AL; Xu H; Fischer S; Zou C; Yang X; Steele VE; Kelloff GJ; Lotan R; Clifford JL
Clin Cancer Res; 2003 Oct; 9(12):4606-13. PubMed ID: 14555536
[TBL] [Abstract][Full Text] [Related]
10. Combinational treatment with retinoic acid derivatives in non-small cell lung carcinoma in vitro.
Choi EJ; Whang YM; Kim SJ; Kim HJ; Kim YH
J Korean Med Sci; 2007 Sep; 22 Suppl(Suppl):S52-60. PubMed ID: 17923756
[TBL] [Abstract][Full Text] [Related]
11. Novel retinoic acid derivative ABPN has potent inhibitory activity on cell growth and apoptosis in cancer cells.
Um SJ; Han HS; Kwon YJ; Park SH; Rho YS; Sin HS; Park JS
Int J Cancer; 2003 Dec; 107(6):1038-46. PubMed ID: 14601067
[TBL] [Abstract][Full Text] [Related]
12. Stage-specific effect of N-(4-hydroxyphenyl)retinamide on cell growth in squamous cell carcinogenesis.
Kabbout M; Hatoum A; Abou-Lteif G; Chakroun I; Homaidan FR; Darwiche N
Mol Carcinog; 2004 May; 40(1):12-23. PubMed ID: 15108326
[TBL] [Abstract][Full Text] [Related]
13. Antitumor activity of the retinoid-related molecules (E)-3-(4'-hydroxy-3'-adamantylbiphenyl-4-yl)acrylic acid (ST1926) and 6-[3-(1-adamantyl)-4-hydroxyphenyl]-2-naphthalene carboxylic acid (CD437) in F9 teratocarcinoma: Role of retinoic acid receptor gamma and retinoid-independent pathways.
Parrella E; Giannì M; Fratelli M; Barzago MM; Raska I; Diomede L; Kurosaki M; Pisano C; Carminati P; Merlini L; Dallavalle S; Tavecchio M; Rochette-Egly C; Terao M; Garattini E
Mol Pharmacol; 2006 Sep; 70(3):909-24. PubMed ID: 16788091
[TBL] [Abstract][Full Text] [Related]
14. Chemoprevention of skin carcinogenesis by phenylretinamides: retinoid receptor-independent tumor suppression.
Xu H; Cheepala S; McCauley E; Coombes K; Xiao L; Fischer SM; Clifford JL
Clin Cancer Res; 2006 Feb; 12(3 Pt 1):969-79. PubMed ID: 16467112
[TBL] [Abstract][Full Text] [Related]
15. Effects of novel all-trans retinoic acid retinamide derivatives on the proliferation and apoptosis of human lung adenocarcinoma cell line A549 cells.
Gui SY; Chen FH; Zhou Q; Wang Y
Yakugaku Zasshi; 2011; 131(10):1465-72. PubMed ID: 21963974
[TBL] [Abstract][Full Text] [Related]
16. Is growth inhibition and induction of apoptosis in lung cancer cell lines by fenretinide [N-(4-hydroxyphenyl)retinamide] sufficient for cancer therapy?
Ohlmann CH; Jung C; Jaques G
Int J Cancer; 2002 Aug; 100(5):520-6. PubMed ID: 12124800
[TBL] [Abstract][Full Text] [Related]
17. N-(4-hydroxyphenyl)retinamide induces apoptosis of malignant hemopoietic cell lines including those unresponsive to retinoic acid.
Delia D; Aiello A; Lombardi L; Pelicci PG; Grignani F; Grignani F; Formelli F; Menard S; Costa A; Veronesi U
Cancer Res; 1993 Dec; 53(24):6036-41. PubMed ID: 8261419
[TBL] [Abstract][Full Text] [Related]
18. Biotransformation and biological activity of N-(4-hydroxyphenyl)retinamide derivatives in rodents.
Swanson BN; Newton DL; Roller PP; Sporn MB
J Pharmacol Exp Ther; 1981 Dec; 219(3):632-7. PubMed ID: 6170750
[TBL] [Abstract][Full Text] [Related]
19. 4HPR triggers apoptosis but not differentiation in retinoid sensitive and resistant human embryonal carcinoma cells through an RARgamma independent pathway.
Kitareewan S; Spinella MJ; Allopenna J; Reczek PR; Dmitrovsky E
Oncogene; 1999 Oct; 18(42):5747-55. PubMed ID: 10523855
[TBL] [Abstract][Full Text] [Related]
20. Growth suppression of human breast carcinoma cells in culture by N-(4-hydroxyphenyl)retinamide and its glucuronide and through synergism with glucarate.
Bhatnagar R; Abou-Issa H; Curley RW; Koolemans-Beynen A; Moeschberger ML; Webb TE
Biochem Pharmacol; 1991 May; 41(10):1471-7. PubMed ID: 1826840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
